These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11610 related articles for article (PubMed ID: 10661764)

  • 21. Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis.
    Nicknam MH; Mahmoudi M; Amirzargar AA; Ganjalikhani Hakemi M; Khosravi F; Jamshidi AR; Amirkhani A; Ansaripour B; Pourpak Z; Moin M; Nikbin B
    Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):19-24. PubMed ID: 18322308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
    Cain CT; Niemann TH; Argenyi ZB
    Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of rheumatoid arthritis with Kartagener's syndrome in a patient with HLA-DR1-DR4-B27 haplotype.
    Beutler A; Mackiewicz SH
    Z Rheumatol; 1992; 51(5):253-5. PubMed ID: 1476011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA and multiple skin carcinomas.
    Cerimele D; Contu L; Carcassi C; Costa G; La Nasa G; Sanna E; Campus GV
    Dermatologica; 1988; 176(4):176-81. PubMed ID: 3378654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin.
    Ribeiro D; Narikawa S; Marques ME
    Pathol Res Pract; 2008; 204(2):97-104. PubMed ID: 18079070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human leukocyte antigen B27 and B51 double-positive Behçet uveitis.
    Ahn JK; Park YG
    Arch Ophthalmol; 2007 Oct; 125(10):1375-80. PubMed ID: 17923546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-B27 and immunogenetics of spondyloarthropathies.
    Alvarez I; López de Castro JA
    Curr Opin Rheumatol; 2000 Jul; 12(4):248-53. PubMed ID: 10910175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin cancers and HLA frequencies in renal transplant recipients.
    Czarnecki D; Watkins F; Leahy S; Dyall-Smith D; Levis A; Nicholson I; Tait B
    Dermatology; 1992; 185(1):9-11. PubMed ID: 1638083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma.
    Stephenson TJ; Royds J; Silcocks PB; Bleehen SS
    Br J Dermatol; 1992 Dec; 127(6):566-70. PubMed ID: 1476915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 'Anti-metastatic' nm23 gene product expression in keratoacanthoma and squamous cell carcinoma.
    Stephenson TJ; Royds JA; Bleehen SS; Silcocks PB; Rees RC
    Dermatology; 1993; 187(2):95-9. PubMed ID: 8358113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel HLA-B27 allele (B*2711) encoding an antigen reacting with both B27- and B40-specific antisera.
    Hasegawa T; Ogawa A; Sugahara Y; Moriyama Y; Nanzai H; Tawara K; Tokunaga K; Juji T; Kondo S
    Tissue Antigens; 1997 Jun; 49(6):649-52. PubMed ID: 9234489
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of an antisquamous antibody in multiple keratoacanthoma.
    Ahmed AR; Sofen H; Saxon A
    Clin Immunol Immunopathol; 1982 Jan; 22(1):20-31. PubMed ID: 6749353
    [No Abstract]   [Full Text] [Related]  

  • 33. Complete coding sequence of HLA-B*2712: a serologic B27-negative antigen associated to Bw6.
    Balas A; Santos S; García-Sánchez F; Lillo R; Merino JL; Vicario JL
    Tissue Antigens; 1998 Apr; 51(4 Pt 1):394-7. PubMed ID: 9583813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal antigens in experimental keratoacanthoma and squamous cell carcinoma.
    Muller HK; Flannery GR
    Cancer Res; 1973 Sep; 33(9):2181-6. PubMed ID: 4579775
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunogenetic study of the HLA system in families of patients with ankylosing spondylitis].
    Grubić Z; Kerhin-Brkljacić V; Cecuk-Jelicić E; Kastelan A
    Reumatizam; 2000; 47(1):13-9. PubMed ID: 11552604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human leukocyte antigen associations in basal cell carcinoma.
    Myskowski PL; Pollack MS; Schorr E; Dupont B; Safai B
    J Am Acad Dermatol; 1985 Jun; 12(6):997-1000. PubMed ID: 3874217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Squamous Cell Carcinoma Arising From Keratoacanthoma: An Evaluation by RT-PCR.
    Ni C; Su A; Ra S; Li X; Cochran A; Binder S
    Am J Dermatopathol; 2016 Mar; 38(3):247-9. PubMed ID: 26067455
    [No Abstract]   [Full Text] [Related]  

  • 38. Sex ratios and hormones in HLA related rheumatic diseases.
    James WH
    Ann Rheum Dis; 1991 Jun; 50(6):401-4. PubMed ID: 2059084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression in skin tumours: a common phenomenon.
    Barnetson RS; Halliday GM
    Australas J Dermatol; 1997 Jun; 38 Suppl 1():S63-5. PubMed ID: 10994476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-B27 and HLA-B73 polymorphism and its role on antigenicity, peptide presentation, and disease susceptibility.
    Lopez De Castro JA
    Clin Rheumatol; 1996 Jan; 15 Suppl 1():67-71. PubMed ID: 8835507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 581.